We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Noninvasive Ventilators Improve COPD Outcomes

By HospiMedica International staff writers
Posted on 17 Feb 2020
Home bilevel positive airway pressure (BiPAP) is associated with lower risk of mortality, all-cause hospital admission, and intubation, according to a new study. More...


Researchers at the Mayo Clinic (Rochester, MN, USA) conducted a meta-analysis of randomized clinical trials (RCTs) and comparative observational studies that enrolled adults with chronic obstructive pulmonary disease (COPD) with hypercapnia who used home noninvasive positive pressure ventilation (NIPPV) devices for more than one month in order to evaluate associations between BiPAP and NIPPV devices and long-term outcomes. In all, 33 studies evaluating outcomes for 51,085 patients were included in the analysis.

The primary outcomes including mortality, all-cause hospital admissions, need for intubation, and quality of life. The results revealed that use of a noninvasive ventilator device (either BiPAP or NIPPV) was significantly associated with lower mortality (29.2%) compared to no device (22.3%). The use of a noninvasive ventilator device also led to fewer emergency department visits and hospitalizations, and lower rates of intubation if the patients were subsequently admitted to the hospital. The study was published on February 4, 2020, in JAMA.

“While there does seem to be some clear benefits to using devices such as BiPAP, we should be cautious as the studies included a lot of different types of patients with COPD. We still have a lot more to learn about which machine settings are best for different types of patients,” said lead author pulmonary and critical care physician Michael Wilson, MD. “In addition, although many studies in our review included quality of life measurements, we didn't see an improvement. While some studies showed better quality of life, other studies showed no difference.”

COPD is a debilitating lung disease that makes it difficult to breathe. Many of those who suffer from COPD also suffer from hypercapnia, the retention of carbon dioxide (CO2), a metabolism waste product normally expelled by the lungs during breathing. The combination of COPD and chronic hypercapnia may lead to acute respiratory failure and hospitalization. One of the recommended treatment options is NIPPV using a respiration machine with a mask that helps to improve breathing.

Related Links:
Mayo Clinic


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.